|
|
Freeze-dried solid. |
|
Specific activity: ~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
IC50 = 28 nM
using ADP-stimulated human platelets (platelet aggregation assay)(4). |
|
[125I]Echistatin
is supplied as a freeze-dried solid in 370 kBq, 10 µCi and 925 kBq, 25
µCi pack sizes. |
|
|
|
|
(3-[125I]iodotyrosyl27)b-Endorphin, human |
|
|
Freeze-dried solid. |
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
Made to order, please inquire for availability. |
|
|
|
|
(3-[125I]iodotyrosyl)Endothelin-1 |
|
|
1:1 solution of Tris HCl (0.08 M), BSA (0.25%) aprotinin (0.01
mg/ml):n-propanol. |
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
3.7 MBq/ml, 100 µCi/ml. |
|
|
|
|
(3-[125I]iodotyrosyl 6)Endothelin-3, human |
|
|
Freeze-dried solid. |
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
Made to order, please inquire for availability. |
|
|
|
|
[d-ala2, N-methyl-phe4, glyol5] [tyrosyl-3,5-3H]Enkephalin |
|
|
0.15 M Triethylammonium phosphate buffer, pH 4.2: acetonitrile (22:3)
solution. |
|
1.48-2.96 TBq/mmol, 40-80
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
|
|
Freeze-dried solid. |
|
Specific activity: ~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
Ki = 0.1 nM
(CCR3/AML14.3D10 cells)(4). |
|
[125I]Eotaxin,
human recombinant is supplied as a freeze-dried solid in 370 kBq, 10 µCi
and 925 kBq, 25 µCi pack sizes. |
|
|
|
|
|
|
Ethanol solution. |
|
1.11-2.22 TBq/mmol, 30-60
Ci/mmol. |
|
3.7 MBq/ml, 100 µCi/ml. |
|
|
|
|
(3-[125I]iodotyrosyl)Epidermal growth factor, human recombinant
([125I]EGF) |
|
|
Aqueous solution. |
|
> 27.75 TBq/mmol, > 750 Ci/mmol. |
|
3.7 MBq/ml, 100 µCi/ml. |
|
|
|
|
(3-[125I]iodotyrosyl)Epidermal growth factor, mouse ([125I]EGF)
|
|
|
Phosphate buffer containing BSA (1 mg/ml). |
|
2.96-4.44 MBq/µg, 80-120
µCi/µg. |
|
1.85 MBq/ml, 50 µCi/ml. |
|
|
|
|
(3-[125I]iodotyrosyl)Erythropoietin, human recombinant (high
specific activity) |
|
|
Solution in 0.1 M sodium acetate, 0.1 M sodium chloride containing 0.2%
BSA. |
|
> 92.5 TBq/mmol, >
2500 Ci/mmol |
|
740 kBq/ml, 20 µCi/ml. |
|
|
|
|
(3-[125I]iodotyrosyl)Erythropoietin, human recombinant |
|
|
Solution in 0.1 M sodium acetate, 0.1 M sodium chloride solution
containing 0.2% BSA. |
|
14.8-44.4 TBq/mmol, 400-1200
Ci/mmol. |
|
740 kBq/ml, 20 µCi/ml. |
|
|
|
|
[2,4,6,7,16,17-3H]Estradiol |
|
|
Toluene:ethanol (9:1) solution. |
|
4.44-6.66 TBq/mmol, 120-180
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
|
|
Toluene:ethanol (9:1) solution. |
|
2.59-4.44 TBq/mmol, 70-120
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
Estradiol-6-(O-carboxymethyl)oximino- (2-[125I]iodohistamine) |
|
|
Methanol:water (9:1) solution. |
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
3.7 MBq/ml, 100 µCi/ml. |
|
|
|
|
|
|
Toluene:ethanol (95:5) solution. |
|
2.96-4.44 TBq/mmol, 80-120
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
[2-14C]Ethan-1-ol-2-amine hydrochloride |
|
|
Aqueous solution, sterilized. |
|
1.85-2.29 GBq/mmol, 50-62
mCi/mmol. |
|
7.4 MBq/ml, 200 µCi/ml. |
|
|
|
|
[1-3H]Ethan-1-ol-2-amine hydrochloride |
|
|
Aqueous solution, sterilized. |
|
0.56-1.48 TBq/mmol, 15-40
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
|
|
Solid in a sealed ampoule. |
|
> 1.85 GBq/mmol, > 50 mCi/mmol. |
|
|
|
|
|
|
Liquid in sealed ampoule. |
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
Available 4 weeks from date of order. |
|
|
|
|
Ethyl bromo[1-14C]acetate |
|
|
Liquid in break-seal
ampoule. |
|
1.85-2.22 GBq/mmol, 50-60 mCi/mmol. |
|
|
|
|
5'-N-Ethylcarboxamido[8(n)-3H]adenosine |
|
|
Ethanol:water (1:1) solution. |
|
0.74-1.5 TBq/mmol, 20-40
Ci/mmol. |
|
37 MBq/ml, 1 mCi/ml. |
|
|
|
|
[U-14C]Ethylene dibromide |
|
|
Liquid in break-seal
ampoule. |
|
3.7-4.44 GBq/mmol, 100-120 mCi/mmol. |
|